Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 of 15 nM. Phase 2.
Catalog | OFC729607743 |
CAS | 729607-74-3 |
Category | Fluorinated APIs |
Synonyms | HIV Integrase Inhibitor |
Purity | >98% |
※ Please kindly note that our products are for research use only.
IUPAC Name | 2-(1,1-dioxothiazinan-2-yl)-N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxopyrimidine-4-carboxamide |
InChI | InChI=1S/C17H19FN4O5S/c1-21-16(25)14(23)13(15(24)19-10-11-4-6-12(18)7-5-11)20-17(21)22-8-2-3-9-28(22,26)27/h4-7,23H,2-3,8-10H2,1H3,(H,19,24) |
InChI Key | VNIWZCGZPBJWBI-UHFFFAOYSA-N |
Isomeric SMILES | CN1C(=O)C(=C(N=C1N2CCCCS2(=O)=O)C(=O)NCC3=CC=C(C=C3)F)O |
Molecular Formula | C17H19FN4O5S |
Molecular Weight | 410.42 |
Appearance | White to off-white solid powder |
XLogP3-AA | 1 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 4 |
Exact Mass | 410.10601905 g/mol |
Monoisotopic Mass | 410.10601905 g/mol |
Topological Polar Surface Area | 128Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 812 |
Please kindly note that our products and services are for research use only.